Narrow search
Showing 1 - 10 of 249
Cover Image
Discussion Note: Draft National Pharmaceutical Policy 2006
Network, All-India Drug Action - eSocialSciences - 2006
A note on the long-awaited Draft National Pharmaceutical Policy 2006. The Policy appears to have taken into consideration consumer needs, paying respect to rational therapeutics. A closer examination of the details---which is what policy critique should do—shows a patchy effort that may...
Persistent link: https://www.econbiz.de/10005696014
Cover Image
The Sectoral System of Innovation of Indian Pharmaceutical Industry
Mani, Sunil - eSocialSciences - 2008
discovery of drugs for neglected diseases of the developing world. Although the innovation system has the capability to develop …
Persistent link: https://www.econbiz.de/10005699264
Cover Image
Pharmaceuticals, WTO/TRIPs and Women
Srinivasan, S - eSocialSciences - 2005
This paper looks at the effects of WTO/TRIPS and pharmaceuticals on women. The focus is on the poor and women. The … benefits of health and modern pharmaceuticals. Access to generic low-priced medicines – including medicines for HIV AIDS …
Persistent link: https://www.econbiz.de/10005699276
Cover Image
R&D for Development of New Drugs for Neglected Diseases How Can India Contribte?
Chaudhuri, Sudip - eSocialSciences - 2009
The focus of this paper is India. In line with TRIPS India has introduced a product patent regime in pharmaceuticals … from 1 January, 2005. WIll this lead increase in resources deveoted to R and D by Indian companies for the development of … for developing new drugs for neglected diseases? Can India contribte to lowering the cost of new drug development and make …
Persistent link: https://www.econbiz.de/10004988399
Cover Image
Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review
Austad, Kirsten E; Avorn, Jerry; Kesselheim, Aaron S - eSocialSciences - 2011
development. A search in MEDLINE, EMBASE, Web of Science, and ERIC from the earliest available dates through May 2010, as well as …
Persistent link: https://www.econbiz.de/10009323690
Cover Image
The Drugs And Cosmetics (Amendment) Bill, 2005
eSocialSciences - 2005
THE DRUGS AND COSMETICS (AMENDMENT) BILL, 2005 A Bill further to amend the Drugs and Cosmetics Act, 1940. Under examination with the Committee on Health and Family Welfare On adulterated and spurious drugs
Persistent link: https://www.econbiz.de/10005528115
Cover Image
Task Force to Explore Options other than Price Control for Achieving the Objective of Making Available Life-saving Drugs at Reasonable Prices
Pricing, Task Force on Pharmaceutical - eSocialSciences - 2005
The Task Force recommends that price regulation should be on the basis of ‘Essentiality’ of the drug and it should be applied only to formulations and not to upstream products, such as bulk drugs. No effort should be made to impose a uniform price, and only a ceiling price should be...
Persistent link: https://www.econbiz.de/10005528148
Cover Image
Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India
Chaudhuri, Shubham; Goldberg, Pinelopi K.; Jia, Panle - eSocialSciences - 2006
product patents for pharmaceuticals, this paper provides a rigorously-derived estimate of the possible impact of …-bacterials (i.e., antibiotics) in the Indian pharmaceuticals market. These estimates are then used to carry out counterfactual …
Persistent link: https://www.econbiz.de/10005528220
Cover Image
Guidelines for the Examination of Pharmaceutical Patents: Developing a Public Health Perspective
Correa, Carlos - eSocialSciences - 2007
examination for pharmaceuticals inventions, particularly in developing countries. It proposes a set of general guidelines for the … assessment of some of the common modalities of pharmaceutical patent claims, and suggests elements for the development of public …
Persistent link: https://www.econbiz.de/10005528232
Cover Image
Intellectual Property and Access to Medicines
Onori, Andrea - eSocialSciences - 2007
This report analyzes the ITRIPS agreement. It discuses the problems and stakes, and consequences of this agreement. The report also provides case studies related to the topic and finally gives a suggestive conclusion.
Persistent link: https://www.econbiz.de/10005528311